Right-Sided Valve Disease in Adults


The importance of right-sided valve disease was underappreciated for decades, largely because tricuspid and pulmonary valve diseases have a prolonged latency phase before the onset of overt symptoms. Tricuspid regurgitation (TR) is frequently caused by another predisposing disease process that may dominate the clinical presentation.

There is a growing recognition that tricuspid valve (TV) and pulmonary valve (PV) diseases are independently associated with increased morbidity and mortality. This has generated interest in understanding the mechanisms of valvular dysfunction and the physiologic impact of these lesions on right ventricular (RV) function.

Emerging percutaneous structural heart interventions may offer alternatives to traditional surgery with less morbidity. Echocardiography plays a critical role in diagnosing and quantifying TV and PV disease, and it is essential to guiding the clinical care of these patients ( Table 28.1 ).

TABLE 28.1
Echocardiographic Assessment of the Tricuspid and Pulmonary Valves: Right-Sided Stenotic and Regurgitant Lesions.
Valve Modality Valve Anatomy Modality Quantification
Tricuspid valve 2D Anatomic assessment: PSS, PSL, A4C, and SC
TV annular diameter: A4C
CW PSS, PSL, A4C and para-apical
3D PSS, PSL, A4C, SC PW Hepatic reversals: SC
TEE Mid/distal esophagus 4-chamber
Transgastric 0–30 degrees
Color TR jet area: A4C or para-apical
Vena contracta: A4C
PISA: A4C or para-apical
Pulmonary valve 2D Anatomic assessment: PSS, PSS with anterior/superior angulation (RV outflow view), anterior angulation from 4-chamber SC or basal short-axis SC CW PSS and modified PSS (RV inflow view)
Basal short-axis SC
4-chamber SC
3D PSS and modified PSS (RV inflow view)
Basal short-axis SC
4-chamber SC
PW PSS and modified PSS (RV inflow view)
Basal short-axis SC
4-chamber SC
TEE Mid-esophageal 45–60 and 110–130 degrees
High esophageal 0–30 degrees
Transgastric 60 degrees
Color PSS and modified PSS (RV inflow view)
Basal short-axis SC
4-chamber SC
A4C , Apical 4-chamber view; PISA , proximal isovelocity surface area; PSL , parasternal long-axis view; PSS , parasternal short-axis view; PW , pulsed wave; SC , subcostal view; TR , tricuspid regurgitation; TV , tricuspid valve.

Tricuspid Valve Disease

Tricuspid Valve Anatomy

The TV is composed of three leaflets: septal, anterior, and posterior ( Fig. 28.1 ). They create a triangular orifice flanked by the ostium of the coronary sinus, the right coronary artery, and the atrioventricular node. The noncoronary sinus of Valsalva lies immediately behind the anterior and septal leaflet commissure.

Fig. 28.1, Tricuspid valve anatomy.

The TV leaflets are asymmetric; the largest and most mobile is the anterior leaflet, whereas the septal leaflet is the smallest and least mobile. Typically, the anterior and posterior leaflets are attached to the anterior papillary muscle, and the posterior and septal leaflets insert into the posterior papillary muscle. However, variations are common, and a third rudimentary papillary muscle may exist at the chordal insertion into the ventricular septum. ,

The TV annulus is large, with an average orifice area of 7 to 9 cm 2 and an average diastolic diameter of 2.5 ± 0.5 cm. The elliptical annulus is shaped like a saddle. The posteroseptal portion is tipped toward the RV apex, and the anteroseptal portion angles up toward the right atrium (RA). , , The coaptation length is between 5 and 10 mm, which allows moderate annular dilation to occur before the development of TR. Coaptation occurs at the level of the annulus or slightly ventricular to the annulus. The TV annulus has relatively little fibrous tissue, which allows for significant changes in the annular area and regurgitate orifice to occur with the cardiac and respiratory cycle and with variations in loading conditions. ,

Tricuspid Regurgitation

Background

TR affects 80% of the population. Moderate-severe or worse TR affects approximately 1.6 million Americans. , As shown in Table 28.2 , TR has many causes. Primary TR due to leaflet abnormalities occurs in approximately 10% of patients with TR and is most commonly caused by congenital heart disease, carcinoid syndrome, rheumatic valve disease, infective endocarditis, toxic drug exposure, or flail leaflet after blunt chest trauma.

TABLE 28.2
Causes of Tricuspid Regurgitation. a
Lesion Causes
Primary Tricuspid Regurgitation
Congenital Ebstein anomaly
Leaflet prolapse
Congenitally corrected transposition
Atrioventricular septal defect
Tricuspid dysplasia
Infectious or inflammatory Rheumatic fever
Radiation exposure
Carcinoid
Infective endocarditis
Marantic endocarditis
Leaflet damage Endomyocardial biopsy
Device leads
Drug-induced Fenfluramine
Ergots
Pergolide
Secondary Tricuspid Regurgitation
Pulmonary hypertension Pulmonary vascular disease
Congestive heart failure
Aortic valve disease
Mitral valve disease
RV dysfunction RV infarction
Arrhythmogenic RV cardiomyopathy
RV volume overload Left-to-right shunt
High-output states
Idiopathic Atrial fibrillation

a Classically, tricuspid regurgitation is categorized as primary, meaning that regurgitation results from a primary anatomic abnormality, or secondary, meaning that regurgitation is a secondary consequence of another disease process.

A growing patient population has primary isolated TR due to endomyocardial biopsy or intracardiac device leads. , The true incidence of TR after endomyocardial biopsy is unknown, but moderate or worse TR has been reported for 14% to 33% of orthotopic heart transplant patients undergoing repeated biopsies over long-term follow-up. , Device leads are an underappreciated cause of primary isolated TR. In a series of 239 patients undergoing de novo ventricular lead implantation, 38% developed new TR of 2+ or greater.

Ninety percent of severe TR cases are secondary (i.e., functional), meaning that the TR is mediated by RV and/or RA enlargement. The most common cause of secondary TR is pulmonary hypertension (PH) resulting from intrinsic pulmonary vascular disease or elevation of the pulmonary artery wedge pressure due to left-sided heart disease. Over time, chronic pressure overload causes the RV to dilate, resulting in papillary muscle displacement and lateral annular dilation with resultant leaflet malcoaptation ( Fig. 28.2 ). As the annulus dilates, the TV loses its normal tipped-down elliptical shape and assumes a planar orientation with a circular orifice. , Recirculation of the regurgitant volume (RVol) creates chronic RV volume overload, causing the RV to further dilate and creating a cycle in which severe TR begets more severe TR.

Fig. 28.2, Mechanism of secondary tricuspid regurgitation.

An emerging population of adult patients has isolated TR in the absence of left-sided heart disease, PH, or congenital abnormalities. Most cases of isolated TR result from direct leaflet displacement or damage from RV pacemaker or defibrillator leads or from TV annular dilation due to RA enlargement caused by long-standing atrial fibrillation. , Isolated TR is associated with a poor long-term prognosis, even in the absence of other cardiopulmonary comorbities. ,

Basic Echocardiographic Imaging Principles

The symptoms and physical examination findings of TR can be nonspecific, and as a result, most cases of TR are diagnosed during echocardiography. When more than mild TR is appreciated on transthoracic echocardiography (TTE), a more thorough assessment of the mechanism and severity of TR is mandatory. Defining the mechanism and severity of TR is essential for determining the appropriate treatment. Patients with primary or isolated TR may benefit from surgical correction, whereas many patients with secondary TR are best served by treating the predisposing disease process ( Table 28.3 ).

TABLE 28.3
Guidelines for the Surgical Treatment of Tricuspid Regurgitation.
European Society of Cardiology Recommendations American Heart Association/American College of Cardiology Recommendations
Class I
Severe primary or secondary TR at the time of surgery for left-sided valve disease (LOE C) Severe primary or secondary TR (stages C or D) undergoing left-sided valve surgery (LOE B)
Isolated symptomatic severe primary TR with preserved RV function (LOE C)
Class IIa
Surgery may be appropriate to treat moderate primary TR at the time of left-sided valve surgery (LOE C) Surgery may be appropriate to treat severe primary TR when signs and symptoms of right-sided heart failure are present (LOE B)
Surgery may be appropriate for mild or worse secondary TR at the time of left-sided valve surgery if severe annular dilation exists (≥40 mm or or diameter indexed to body surface area ≥21 mm/m 2 ) (LOE C) Surgery may be appropriate to alleviate symptoms in patients with progressive TR (stage B) undergoing left-sided valve surgery when there is severe annular dilation (end diastolic annular diameter >4 cm) or signs or symptoms of right-sided heart failure are present (LOE B)
Surgery may be appropriate for asymptomatic patients with severe isolated primary TR and evidence of progressive RV dilation or decreased RV function (LOE C) Surgery may be appropriate to alleviate symptoms in patients with severe isolated secondary TR due to annular dilation (in the absence of significant left-sided heart disease or pulmonary hypertension) who have an inadequate response to medical therapy (stage D) (LOE B)
In patients with previous left-sided valve surgery; isolated TV surgery may be appropriate for those with severe secondary TR and with symptoms or evidence of RV dilation or dysfunction in the absence of left-sided valve dysfunction, severe RV or LV dysfunction, and severe pulmonary hypertension (LOE C)
Class IIb
For patients with previous left-sided valve surgery, surgery may be appropriate for patients with symptomatic severe TR (stage D) in the absence of severe pulmonary hypertension or severe RV systolic dysfunction (LOE B)
Surgery may be appropriate for patients with asymptomatic severe primary TR (stage C) and progressive RV dilation or systolic dysfunction (LOE C)
LOE , Level of evidence; TR , tricuspid regurgitation; TV , tricuspid valve.
Stage B: Progressive TR (physical exam without signs of elevated venous pressure and no clinical symptoms; TTE findings of central TR jet <50% RA diameter, VC < 0.7 cm, ERO < 0.4cm 2 , RV < 45 mL).
Stage C: Asymptomatic severe TR (physical exam with signs of elevated venous pressure but without clinical symptoms; TTE findings of central TR jet ≥50% RA area, VC ≥ 0.7 cm, ERO ≥ 0.4 cm 2 , RV ≥ 45 mL, dense triangular CW signal, hepatic vein systolic reversal, dilated RA and RV, RA with “c-V” wave).
Stage D: Symptomatic severe TR (physical exam with signs of elevated venous pressure and patient with right-sided heart failure symptoms; TTE findings of central TR jet ≥50% RA, VC ≥ 0.7 cm, ERO ≥ 0.4 cm 2 , RV ≥ 45 mL, dense triangular CW signal, hepatic vein systolic reversal, dilated RA and RV, RA with “c-V” wave, clinical signs of elevated venous pressure).

Assessing the Mechanism and Severity of Tricuspid Regurgitation

A comprehensive TTE assessment of the TV should be performed in all patients with more than mild TR. TTE has several goals:

  • 1.

    Define the mechanism of TR

  • 2.

    Quantify the severity of regurgitation

  • 3.

    Screen for PH and left-sided heart disease

  • 4.

    Assess RV size and function

Echocardiographic assessment of the TV involves a systematic and stepwise interrogation of the TV from four main views; the parasternal short- and long-axis views, the apical 4-chamber view, and the subcostal windows. The RV inflow view from the parasternal long axis ( Fig. 28.3A ) allows visualization of the RA and the base of the RV. Rotating the probe 90 degrees brings in the parasternal short-axis view at the level of the aortic valve (see Fig. 28.3B ), from which the RA, RV outflow tract (RVOT), TV, and PV can be viewed.

Fig. 28.3, TTE assessment of the tricuspid valve.

The apical 4-chamber view is best for visualization of the RV (see Fig. 28.3C ) and is the view from which quantitative measurements of RV size and strain are performed. When functional TR due to significant aortic or mitral valve disease is suspected, the TV annular diameter should be measured from the apical 4-chamber view (see Fig. 28.3D ). A diastolic diameter of more than 4 cm (or diameter indexed to body surface area of ≥ 21 mm/m 2 ) indicates an increased risk for persistent TR after mitral valve surgery if concomitant TV repair is not performed. , ,

From the parasternal short-axis and apical 4-chamber views, it is possible to visualize the septal and anterior leaflets. The posterior leaflet is best viewed from the apical 4-chamber or subcostal windows by sweeping the probe posteriorly until the coronary sinus is brought into view. However, even with these techniques, correct identification of the individual leaflets is challenging because of anatomic variation. Although it is sometimes forgotten, a short-axis view of the TV on the parasternal short axis should always be attempted because, similar to 3D echocardiography, it provides simultaneous assessment of all three RV leaflets (see Fig. 28.1B ). This can be obtained by tilting the probe inferiorly from the level of the mitral valve; with practice, it can be obtained in a large proportion of patients.

3D echocardiography provides superior visualization of the TV leaflets ( Fig. 28.4 ) by overcoming the challenges of imaging the nonplanar TV annulus. Optimal 3D imaging should include the surrounding anatomic landmarks in the acquisition volume to aid in recognition of the individual leaflets and to define the mechanism of TR. 3D echocardiography is the most accurate method of localizing focal anatomic disease such as infective endocarditis, intracardiac device lead impingement, or flail leaflet. Transthoracic 3D volumes can be obtained in the parasternal, apical, or subcostal window, but the apical window is typically best because of the anterior location of the RV near the chest wall and the perpendicular orientation of the TV relative to the ultrasound probe. Parasternal short- or long-axis views may also provide high-quality 3D images, and they allow improved spatial resolution because the TV lies in the parasternal near field.

Fig. 28.4, 3D assessment of tricuspid valve anatomy.

Anatomic assessment of the leaflets is essential for identifying the cause of TR ( Fig. 28.5 ) and referring patients for appropriate therapy. Flail leaflet may result from myxomatous degeneration, infective endocarditis, blunt chest trauma, cardiac lead device extraction, or endomyocardial biopsy. Infective endocarditis may also result in leaflet perforation or leaflet destruction, or a large vegetation may interrupt coaptation. Rheumatic heart disease commonly causes combined regurgitation and stenosis due to commissural fusion with shortening and retraction of the leaflets and chordae. Carcinoid syndrome and serotonergic or dopaminergic drugs induce fibroproliferative leaflet thickening and reduce leaflet mobility ( Fig. 28.6 ).

Fig. 28.5, Illustrative cases of tricuspid valve pathology.

Fig. 28.6, Carcinoid tricuspid valve disease.

Ebstein anomaly is characterized by in utero failure of leaflet delamination, with subsequent apical displacement of the septal and posterior leaflets into the ventricle ( Fig. 28.7 ). When a congenital cause such as Ebstein anomaly is identified, it is important to screen for associated cardiac defects such as patent foramen ovale, atrial septal defect, and LV noncompaction.

Fig. 28.7, Ebstein anomaly.

Intracardiac devices can induce TR through leaflet impingement, perforation, or adhesions; however, 2D TTE may be insensitive for lead-induced TR. In a series of 41 patients with surgically confirmed lead-induced TR, only 12% of patients were accurately identified by TTE preoperatively. The use of 3D echocardiography and TEE imaging may substantially improve accurate detection of lead-mediated TR.

When TTE does not reveal a primary anatomic cause of TR, it is necessary to screen for predisposing disease processes such as left-to-right shunt, PH, and left-sided heart disease. Echocardiographic assessment of these disease processes is covered in depth in other chapters.

In approximately 10% of patients with secondary TR, a predisposing cause cannot be identified. , , These patients tend to be elderly and female and have a high prevalence of atrial fibrillation. , , Echocardiographic assessment of isolated TR in patients with atrial fibrillation and no other cardiopulmonary comorbidities has identified a unique pattern of RA enlargement and annular dilation out of proportion to RV enlargement, suggesting that atrial fibrillation may be a cause rather than a consequence of TR.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here